Synthetic lethality is a therapeutic strategy specifically designed to induce cell death in cancer cells by targeting genetic vulnerabilities, as described in [1]. This relationship is further supported by academic literature linking the two concepts in the context of cancer treatment development [2] and the study of DNA-targeted drugs for cancer [3].